温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.poz.com/tag/sofosbuvir
点击访问原文链接

sofosbuvir - POZ

进入原网站 导航首页
POZ DirectoryMy AccountHomeBasicsBasicsIntroductionHIV Transmission and RisksHIV TestingHIV PreventionNewly DiagnosedStarting HIV TreatmentHIV MedicationsHIV Drug Assistance ProgramsOther Related ConditionsVIH/SIDA en EspañolNewsNewsNewsfeedScience NewsFeaturesOpinionsConferencesSlideshowsVideosPOZ at HomePOZ TVPOZ StoriesPOZ 100By AuthorRSS LinksHot TopicsHot TopicsPOZ AwardsWorld AIDS DayCriminalizationCureLong-Term SurvivorsNewly DiagnosedPrEPPreventionUndetectable (U=U)YouthMagazineMagazineCurrent IssueArchivesDigital EditionsPOZ FocusPOZ en EspañolSubscriptionsEmail NewslettersBlogsBlogsRecent PostsBrowse BloggersRSS LinksCommunityCommunityPOZ PersonalsPOZ StoriesPOZ 100CommunityAIDS Is EverydayForumsPollsSurveysQuizzesAsk POZAwareness DaysServices DirectoryCalendarJobsBookstoreAbout UsAbout UsAbout UsMastheadAwardsPress ReleasesAdvertiseContact UsSmart + StrongTerms of useYour privacySmart + StrongSmart + StrongTerms of useYour privacySmart + StrongWith No Approved Treatments and Little Support, People With Long COVID Turn to Online Drug MarketsPeople are trying off-label medications, including some approved for treatment of HIV, hepatitis C or acute COVID-19.Vosevi Is Effective for Retreatment of Hepatitis CAdding ribavirin led to more side effects but did not improve the likelihood of a cure.Starting Hepatitis C Treatment at Time of Diagnosis Leads to High Cure RatePairing HCV testing and treatment eliminates the need to navigate the medical system.FDA OKs AbbVie’s Mavyret for All Hepatitis C GenotypesThe two-drug regimen can cure the virus in as little as eight weeks.Eight Weeks of Harvoni Works Well in the Real World, Even in Some Not Approved For Such Short TreatmentReal-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.The 2016 Hepatitis C Drug Approval OutlookHere’s what’s in store this year for new hepatitis C therapies, as well as approvals for new uses of existing treatments.FDA Grants Priority Review to New Gilead Hep C Combo TabletThe status was granted to the investigational pangenotypic hep C fixed-dose combination tablet of Sovaldi/velpatasivr.Major Liver Meeting Points to Continued Progress in Hep C FightHighlights from presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco.Daklinza & Sovaldi Better Treats Those With HIV & HCVDaklinza (daclatasvir) and Sovaldi (sofosbuvir) more effectively cures hepatitis C among those coinfected with HIV than does Sovaldi and...FDA OKs Harvoni for Hep C Genotypes 4, 5, 6, People With HIVThe FDA has approved new indications for Gilead’s Harvoni: to treat hepatitis C in those with genotypes 4–6 of the virus and in those...Gilead Seeks FDA Approval for Hep C Treatment for All GenotypesGilead has applied to the FDA for approval of the combo tablet of Sovaldi and velpatasvir to treat those with genotypes 1 through 6 of...Sovaldi-Based Hep C Regimens Less Successful in Real WorldThe real-world cure rates offered by Sovaldi (sofosbuvir)-based hep C virus regimens have not been as good as those seen in clinical trialsDaklinza/Sovaldi Success for Those With HIV/HCVA look at real-world use of Bristol-Myers Squibb’s Daklinza (daclatasvir) and Gilead Sciences’ Sovaldi (sofosbuvir) showed that, among those c...FDA Green Lights AbbVie’s Technivie for Genotype 4 of Hepatitis CThe FDA has approved AbbVie’s single-tablet combination regimen Technivie plus ribavirin to treat genotype 4 of hepatitis C virus among...Liver Association Updates Hepatitis C Treatment GuidelinesThe American Association for the Study of Liver Diseases has updated the treatment guidelines for hepatitis C.How Sure Is a Hep C Cure?Once you’ve officially rid yourself of hepatitis C, how certain can you be that the virus is gone for good?Click hereOur Privacy PolicyManagePrivacy PolicyCookie Usage

智能索引记录